BCAX Bicara Therapeutics Inc. - Common Stock
$20,42
Kurs · Mai 20, 2026
Fundamentaldaten per Mai 11, 2026
52W-Spanne
$8–$24
77% of range
Analystenbewertung
BUY
20 analysts
Kursziel
$31
+54% upside
P/E (TTM)
-6.7
ROE
-33.0%
Nettogewinnmarge
—
BCAX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$20.42
Marktkapitalisierung
$953M
P/E (TTM)
-6.7
EPS (TTM)
$-2.52
Umsatz (TTM)
—
Dividendenrendite
—
ROE
-33.0%
Verschuldungsgrad
—
52W-Spanne
$8 – $24
BCAX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
—
EPS
$-2.52
2023-12-31
→
2025-12-31
Freier Cashflow
$-107M
2024-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
BCAX
Peer-Median
P/E (TTM)
-6.7
—
P/B (K/B)
2.4
7.4
Price / FCF (Kurs / FCF)
-8.9
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
BCAX
Peer-Median
ROA
-29.3%
-47.6%
ROE
-33.0%
-62.8%
ROIC
-38.8%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
BCAX
Peer-Median
Current Ratio (Liquiditätsgrad)
14.6
5.6
Quick Ratio
14.3
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
BCAX
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
BCAX
Peer-Median
BCAX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
20 Analysten
- Starker Kauf 6 30,0%
- Kauf 10 50,0%
- Halten 4 20,0%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
13 Analysten · 2026-05-20
Median
$31.00
Jetzt
$20.42
Tief
$16.00
Hoch
$46.00
Median-Ziel
$31.00
+51,8%
Mittelwert-Ziel
$31.46
+54,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.08%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.93 | $-0.77 | -0.16% |
| 31. Dezember 2025 | $-0.68 | $-0.68 | 0.00% |
| 30. September 2025 | $-0.67 | $-0.56 | -0.11% |
| 30. Juni 2025 | $-0.50 | $-0.58 | 0.08% |
| 31. März 2025 | $-0.68 | $-0.42 | -0.26% |
| 31. Dezember 2024 | $-0.39 | $-0.33 | -0.06% |
Vergleich mit Konkurrenten Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| KALV | $685M | -3.7 | — | — | -172.9% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
| OLMA | $2.03B | -13.4 | — | — | -39.4% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| R&D Expense | · | $64M | $31M | |
| SG&A Expense | $31M | $19M | $9M | |
| Operating Expenses | $156M | $82M | $40M | |
| Operating Income | $-156M | $-82M | $-40M | |
| Interest Income | $18M | $15M | $1M | |
| Other Non-op | $18M | $15M | $-12M | |
| Pretax Income | $-138M | $-68M | $-52M | |
| Income Tax | $217.0K | $187.0K | $5.0K | |
| Net Income | $-138M | $-68M | $-52M | |
| EPS (Basic) | $-2.52 | $-4.05 | $-89.61 | |
| EPS (Diluted) | $-2.52 | $-4.05 | $-89.61 | |
| Shares (Basic) | 54,676,896,000 | 16,805,524,000 | 580,109,000 | |
| Shares (Diluted) | 54,676,896,000 | 16,805,524,000 | 580,109,000 | |
| EBITDA | $-156M | $-82M | · |
Bilanz 19
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $97M | $490M | $230M | |
| Short-term Investments | $318M | $0 | · | |
| Prepaid Expense | $7M | $13M | $633.0K | |
| Current Assets | $422M | $503M | $231M | |
| PP&E (Net) | $330.0K | $155.0K | $202.0K | |
| Other Non-current Assets | $7M | $7M | $2M | |
| Total Assets | $431M | $510M | $234M | |
| Accrued Liabilities | · | $13M | $8M | |
| Current Liabilities | $29M | $18M | $15M | |
| Capital Leases | $593.0K | $131.0K | $372.0K | |
| Other Non-current Liabilities | · | $0 | $17.0K | |
| Total Liabilities | $30M | $18M | $15M | |
| Common Stock | $7.0K | $7.0K | $2.0K | |
| Paid-in Capital | $760M | $713M | $4M | |
| Retained Earnings | $-359M | $-221M | $-153M | |
| AOCI | $243.0K | $0 | · | |
| Stockholders' Equity | $401M | $492M | $-149M | |
| Liabilities + Equity | $431M | $510M | $234M | |
| Shares Outstanding | 56,600,724 | 54,440,013 | 640,386 |
Cashflow 10
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Stock-based Comp | $15M | $7M | $2M | |
| Deferred Tax | $0 | $0 | $0 | |
| Operating Cash Flow | $-107M | $-75M | $-46M | |
| CapEx | $280.0K | $71.0K | $586.0K | |
| Investing Cash Flow | $-318M | $-9.0K | $-586.0K | |
| Stock Issued | $29M | $332M | $0 | |
| Net Stock Activity | $29M | $332M | · | |
| Financing Cash Flow | $32M | $334M | $272M | |
| Net Change in Cash | $-393M | $259M | $226M | |
| Free Cash Flow | $-107M | $-75M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| ROA | -29.3% | -18.3% | · | |
| ROE | -33.0% | -13.6% | · | |
| ROIC | -38.8% | -16.8% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 14.6 | 27.9 | · | |
| Quick Ratio | 14.3 | 27.2 | · |
Bewertung (TTM) 8
| Kennzahl | Trend | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Net Income TTM | $-138M | $-68M | · | |
| Market Cap | $953M | $948M | · | |
| P/E | -6.7 | -4.3 | · | |
| P/B | 2.4 | 1.9 | · | |
| P / Tangible Book | 2.4 | 1.9 | · | |
| P / Cash Flow | -8.9 | -12.7 | · | |
| P / FCF | -8.9 | -12.7 | · | |
| Earnings Yield | -15.0% | -23.2% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | $33M | $25M | $34M | · | $16M | $16M | $12M | $10M | |
| SG&A Expense | $13M | $8M | $8M | $7M | $7M | $7M | $5M | $4M | $3M | $3M | |
| Operating Expenses | $60M | $41M | $41M | $32M | $42M | $27M | $21M | $20M | $15M | $14M | |
| Operating Income | $-60M | $-41M | $-41M | $-32M | $-42M | $-27M | $-21M | $-20M | $-15M | $-14M | |
| Interest Income | $4M | $4M | $4M | $5M | $5M | $6M | $3M | $3M | $3M | $1M | |
| Other Non-op | $4M | $4M | $4M | $5M | $5M | $6M | $3M | $3M | $3M | $1M | |
| Pretax Income | $-56M | $-37M | $-36M | $-27M | $-37M | $-21M | $-17M | $-17M | $-13M | $-12M | |
| Income Tax | $52.0K | $53.0K | $40.0K | $52.0K | $72.0K | $186.0K | $0 | $0 | $1.0K | $5.0K | |
| Net Income | $-56M | $-37M | $-36M | $-27M | $-37M | $-21M | $-17M | $-17M | $-13M | $-12M | |
| EPS (Basic) | $-0.93 | $-0.67 | $-0.67 | $-0.50 | $-0.68 | $35.50 | $-1.60 | $-19.01 | $-18.94 | $-19.43 | |
| EPS (Diluted) | $-0.93 | $-0.67 | $-0.67 | $-0.50 | $-0.68 | $35.50 | $-1.60 | $-19.01 | $-18.94 | $-19.43 | |
| Shares (Basic) | 60,717,041 | 54,513,336,391 | 54,563,864 | 54,539,230 | 54,456,515 | 16,793,065,830 | 10,901,138 | 896,744 | 660,288 | 579,545,517 | |
| Shares (Diluted) | 60,717,041 | 54,513,336,391 | 54,563,864 | 54,539,230 | 54,456,515 | 16,793,065,830 | 10,901,138 | 896,744 | 660,288 | 579,545,517 | |
| EBITDA | $-60M | · | $-41M | $-32M | $-42M | · | $-21M | · | · | · |
Bilanz 19
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $323M | $97M | $172M | $437M | $462M | $490M | $521M | · | · | $230M | |
| Short-term Investments | $216M | $318M | $118M | · | · | $0 | · | · | · | · | |
| Prepaid Expense | $5M | $7M | $7M | $8M | $9M | $13M | $756.0K | · | · | $633.0K | |
| Current Assets | $545M | $422M | $297M | $444M | $471M | $503M | $522M | · | · | $231M | |
| PP&E (Net) | $346.0K | $330.0K | $135.0K | $117.0K | $136.0K | $155.0K | $130.0K | · | · | $202.0K | |
| Other Non-current Assets | $7M | $7M | $8M | $7M | $7M | $7M | $2M | · | · | $2M | |
| Total Assets | $554M | $431M | $425M | $454M | $478M | $510M | $524M | · | · | $234M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $8M | |
| Current Liabilities | $39M | $29M | $21M | $17M | $19M | $18M | $14M | · | · | $15M | |
| Capital Leases | $301.0K | $593.0K | $880.0K | $1M | $0 | $131.0K | $137.0K | · | · | $372.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | $0 | · | · | $17.0K | |
| Total Liabilities | $40M | $30M | $22M | $18M | $19M | $18M | $15M | · | · | $15M | |
| Common Stock | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | · | · | $2.0K | |
| Paid-in Capital | $929M | $760M | $724M | $720M | $717M | $713M | $710M | · | · | $4M | |
| Retained Earnings | $-415M | $-359M | $-322M | $-285M | $-258M | $-221M | $-200M | · | · | $-153M | |
| AOCI | $-243.0K | $243.0K | $-136.0K | · | · | $0 | · | · | · | · | |
| Stockholders' Equity | $514M | $401M | $403M | $435M | $459M | $492M | $510M | · | · | $-149M | |
| Liabilities + Equity | $554M | $431M | $425M | $454M | $478M | $510M | $524M | · | · | $234M | |
| Shares Outstanding | 65,547,037 | 56,600,724 | 54,612,477 | 54,556,078 | 54,528,975 | 54,440,013 | 54,409,708 | · | · | 640,386 |
Cashflow 9
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $3M | $3M | $3M | $2M | $1M | $1M | $765.0K | |
| Operating Cash Flow | $-38M | $-24M | $-29M | $-26M | $-28M | $-30M | $-17M | $-13M | $-15M | $-8M | |
| CapEx | $60.0K | $238.0K | $42.0K | $0 | $0 | $40.0K | $8.0K | $19.0K | $4.0K | $436.0K | |
| Investing Cash Flow | $101M | $-82M | $-236M | $0 | $0 | $-40.0K | $-8.0K | $-19.0K | $58.0K | $-436.0K | |
| Stock Issued | $162M | $29M | · | · | $0 | $-1M | · | · | · | $0 | |
| Net Stock Activity | $162M | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $163M | $31M | $436.0K | $135.0K | $460.0K | $-975.0K | $334M | $734.0K | $137.0K | $195M | |
| Net Change in Cash | $227M | $-75M | $-265M | $-25M | $-28M | $-31M | $317M | $-12M | $-14M | $186M | |
| Free Cash Flow | $-38M | · | · | · | $-28M | · | · | · | · | · |
Rentabilität 3
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.9% | · | -7.7% | -12.1% | -15.4% | · | -6.7% | · | · | · | |
| ROE | -11.6% | · | -8.0% | -12.6% | -16.1% | · | -6.9% | · | · | · | |
| ROIC | -11.7% | · | -10.1% | -7.4% | -9.1% | · | -4.0% | · | · | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 13.9 | · | 14.1 | 25.8 | 24.6 | · | 36.0 | · | · | · | |
| Quick Ratio | 13.7 | · | 13.8 | 25.3 | 24.2 | · | 36.0 | · | · | · |
Bewertung (TTM) 8
| Kennzahl | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-157M | · | $-118M | $-99M | $-84M | · | $-70M | · | · | · | |
| Market Cap | $1.30B | · | $862M | $507M | $711M | · | $1.39B | · | · | · | |
| P/E | -7.2 | · | -4.6 | -0.4 | -0.3 | · | -0.3 | · | · | · | |
| P/B | 2.5 | · | 2.1 | 1.2 | 1.5 | · | 2.7 | · | · | · | |
| P / Tangible Book | 2.5 | · | 2.1 | 1.2 | 1.5 | · | 2.7 | · | · | · | |
| P / Cash Flow | -34.8 | · | · | · | -25.3 | · | · | · | · | · | |
| P / FCF | -34.7 | · | · | · | -25.3 | · | · | · | · | · | |
| Earnings Yield | -14.0% | · | -21.9% | -234.5% | -308.8% | · | -305.4% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Nettoergebnis | $-138M | $-68M | $-52M |
| Verwässerte EPS | $-2.52 | $-4.05 | $-89.61 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Liquiditätsgrad | 14.6 | 27.9 | — |
| Quick Ratio | 14.3 | 27.2 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | $-107M | $-75M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.